Treatments:Cancer

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 16: Line 16:
* [[Bortezomib]] - Generic: Velcade
* [[Bortezomib]] - Generic: Velcade
=====Anti-non-small cell lung cacinoma=====
=====Anti-non-small cell lung cacinoma=====
-
* [[Efatinib]] - Generic: Gilotrif; See [[Treatment non-small cell lung carcinoma]]
+
* [[Afatinib]] - Generic: Gilotrif; See [[Treatment non-small cell lung carcinoma]]
* [[Erlotinib]] - Generic: Tarceva
* [[Erlotinib]] - Generic: Tarceva
* [[Gefitinib]] - Generic: Iressa
* [[Gefitinib]] - Generic: Iressa

Revision as of 08:28, 8 January 2025

Anti-CD20 Monoclonal Antibody
Anti-melanoma Monoclonal Antibody
Anti-prostate cancer
Anti-myeloma
Anti-non-small cell lung cacinoma
B-Raf Kinase Inhibitor
  • Zelboraf - Generic: Vemurafenib (Formerly: PLX-4032)
Chemotherapy
Dihydrofolate Reductase Inhibitor
Epidermal Growth Factor Receptor Inhibitors
Estrogen Receptor Modulator
mTOR inhibitor
  • Rapamune - Generic: Sirolimus (Rapamycin)
  • Afinitor - Generic: Everolimus
  • Torisel - Generic: Temsirolimus
Multiple Receptor Tyrosine kinase (VEGFR, PDGFR, EGFR, KIT, Abl, RAF kinase) Inhibitors
Vascular Endothelial Growth Factor Inhibitor
Poly ADP ribose polymerase (PARP) inhibitors
Cyclin-dependent kinases inhibitors

See also Anti-cancer drugs, Anticancer drugs and RAF kinase inhibitors

Proteopedia Page Contributors and Editors (what is this?)

David Canner, Michal Harel, Alexander Berchansky, Karsten Theis

Personal tools